ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Complications, diagnosis, and treatment of odontogenic infections

Complications, diagnosis, and treatment of odontogenic infections
Literature review current through: Jan 2024.
This topic last updated: Jul 21, 2022.

INTRODUCTION — Odontogenic infections, consisting primarily of dental caries and periodontal disease (gingivitis and periodontitis), are common and have local (eg, tooth loss) and, in some cases, systemic implications. In the United States, it is estimated that 25 percent of adults over the age of 60 have lost all their teeth (edentulism), approximately one-half from periodontal disease and one-half from dental caries [1,2].

In addition to producing pain and discomfort, odontogenic infections can extend beyond natural barriers and result in potentially life-threatening complications, such as infections of the deep fascial spaces of the head and neck. (See "Deep neck space infections in adults".)

Periodontal infection can also be associated with a number of systemic disorders. These include fever of unknown origin, bacteremic seeding of heart valves and prosthetic devices, preterm birth of low birth weight children, and an increased risk for coronary heart disease and cerebrovascular events.

The complications, diagnosis, and treatment of odontogenic infections will be reviewed here. The epidemiology, pathogenesis, and clinical manifestations of these infections are discussed separately. (See "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections" and "Overview of gingivitis and periodontitis in adults".)

COMPLICATIONS — Suppurative odontogenic infections may extend to potential fascial spaces in the orofacial area (orofacial space infections) or deep in the head and neck (peripharyngeal space infections). The latter complication is often life threatening. (See "Deep neck space infections in adults".)

In addition, odontogenic infections may spread contiguously to cause osteomyelitis of the jaw or hematogenously to produce systemic illness.

Orofacial space infections — Superficial orofacial space infections can involve the buccal, submental, masticator, canine, and infratemporal spaces. The location of the space infection can assist in recognizing the underlying infected tooth (table 1).

If unrecognized and untreated, these infections are potentially serious since they can spread contiguously into the deeper fascial spaces of the head and neck, such as the submandibular, lateral pharyngeal, and retropharyngeal spaces, or into the carotid sheath. (See "Deep neck space infections in adults".)

The spread of infection into the deeper fascial spaces of the head and neck is suggested by the finding of trismus (the inability to open the jaw). Trismus indicates pressure or infection of the muscles of mastication (the masseter and the pterygoids) or involvement of the motor branch of the trigeminal nerve. Such infections can spread intracranially to cause purulent meningitis or subdural empyema and caudally to result in aspiration, airway obstruction, or fatal necrotizing mediastinitis [3].

Buccal and submental spaces — Infections arising from mandibular or maxillary bicuspid and molar teeth tend to extend in a lateral or buccal direction. The relation of the root apices to the origins of the buccinator muscle determines whether infection will exit intraorally into the buccal vestibule or extraorally into the buccal space (figure 1). Infection of the buccal space is readily diagnosed because of marked cheek swelling with minimal trismus and systemic symptoms.

Involvement of a mandibular incisor can perforate below the mentalis muscle and present as a submental space infection. The chin appears grossly swollen and is firm and erythematous.

Masticator spaces — Masticator spaces consist of the masseteric, pterygoid, and temporal spaces, all of which are well differentiated but intercommunicate with each other as well as with the buccal, submandibular, and lateral pharyngeal spaces (figure 2). Infection of the masticator spaces arises most frequently from molar teeth, particularly the third molars (wisdom teeth). The clinical hallmark of masticator space infection is trismus and pain in the area of the body or ramus of the mandible.

Swelling may not be a prominent finding, especially in the masseteric compartment, since the infection is beneath large muscle masses that can obscure or prevent clinically apparent swelling. When present, swelling tends to be brawny and indurated, suggesting the possibility of cervicofacial actinomycosis or mandibular osteomyelitis. (See "Cervicofacial actinomycosis".)

Infection of the deep temporal space usually originates from involvement of the posterior maxillary molar teeth. Little external swelling is observed early in the course; if present, it usually affects the preauricular region and an area over the zygomatic arch. As infection progresses, the cheek, eyelids, and whole side of the face may be involved. Infection may extend directly into the orbit via the inferior orbital fissure and produce proptosis, optic neuritis, and abducens nerve palsy.

Canine and infratemporal spaces — Involvement of the maxillary incisors and canines may result in a canine space infection, which manifests as dramatic swelling of the upper lip, canine fossa, and frequently the periorbital tissues. Pain is usually moderate, and systemic signs are minimal. Occasionally, direct extension of infection into the adjoining antrum leads to purulent maxillary sinusitis.

The infratemporal space is bounded medially by the lateral plate of the pterygoid process and the pharynx, posteriorly by the parotid gland, anteriorly by the maxilla, and superiorly by the roof of the infratemporal fossa, adjacent to which is the inferior orbital fissure (figure 2).

Primary infections of the infratemporal fossa usually originate from involvement of the posterior maxillary molar teeth, particularly the third molar [4]. Injection of local anesthetic into this area for a dental restoration may predispose to infection.

Clinically, marked trismus and pain are present but very little swelling is observed early in the course. Late manifestations are similar to those of temporal space infections, including extension into the orbit through the inferior orbital fissure. In addition, if the infection extends internally, it can involve an area close to the lateral pharyngeal wall, resulting in dysphagia.

Osteomyelitis of the jaw — Odontogenic infections can spread contiguously to cause osteomyelitis of the jaw. The mandible is much more susceptible to osteomyelitis than the maxilla, primarily because the cortical plates of the former are thin and vascular supply to the medullary tissues is relatively poor. Despite this, osteomyelitis secondary to odontogenic infection is relatively uncommon. When it does occur, there is usually a predisposing condition, such as compound fracture, irradiation, diabetes mellitus, or steroid therapy [5].

With initiation of infection, the intramedullary pressure markedly increases, further compromising blood supply and leading to bone necrosis. Pus travels through the Haversian and perforating canals, accumulates beneath the periosteum, and elevates it from the cortex. If pus continues to accumulate, the periosteum is eventually penetrated, and mucosal or cutaneous abscesses and fistulae can develop. Areas at greatest risk of perforation in the mandible are the lingual aspect in the region of molar teeth and anteriorly on the buccal aspect [3].

As the inflammatory process becomes more chronic, granulation tissue is formed. Spicules of necrotic and nonviable bone may become either totally isolated (sequestrum) or encased in a sheath of new bone (involucrum).

Severe mandibular pain is a common symptom of jaw osteomyelitis and can be accompanied by anesthesia or hypoesthesia on the affected side. In protracted cases, mandibular trismus may develop.

A clinical variant of osteomyelitis of the jaw is Garre chronic sclerosing osteomyelitis or proliferative periostitis [6]. This entity usually occurs in children and young adults following a periapical infection of the mandibular first molar. It is a nonsuppurative form of osteomyelitis characterized by a localized, hard, nontender swelling over the mandible. On radiographic imaging, the newly formed periosteal bone appears as layers outside the cortex, giving a characteristic "onion skin" appearance [7]. Actinomycosis and radiation necrosis are two common causes of this form of osteomyelitis of the jaw [5,8].

A related clinical entity, characterized by exposed necrotic bone in the maxillofacial region, is osteonecrosis of the jaw associated with long-term administration of bisphosphonates for the treatment of osteoporosis or cancer. The prevalence of this condition appears to have escalated, particularly among older female patients [9]. This is discussed in detail separately. (See "Risks of therapy with bone antiresorptive agents in patients with advanced malignancy", section on 'Osteonecrosis of the jaw'.)

Hematogenous dissemination — In addition to contiguous spread, odontogenic infections can disseminate hematogenously to seed native or prosthetic heart valves, joints, or other devices [10]. Although bacteremia can occur following almost all types of dental manipulations, including flossing, scaling, even tooth brushing and chewing hard candy, such episodes are usually transient and inconsequential in healthy individuals [11]. In contrast, the bacteremia in patients with dental caries and periodontal disease tends to be more frequent and sustained [12] and is a potentially important cause of infective endocarditis in older patients, who may be more susceptible due to age-related degenerative or calcified valvular heart disease [13]. (See "Native valve endocarditis: Epidemiology, risk factors, and microbiology".)

Dental sources of bacteremia in older adults are of increasing concern for those undergoing prosthetic heart valve implantation or prosthetic joint replacement. It has been recommended that routine dental assessment be performed in all patients undergoing valve surgery and that appropriate therapeutic interventions be initiated whenever possible before valve implantation [14]. Recommendations regarding the use of antimicrobial prophylaxis for the prevention of bacterial endocarditis in selected patients are presented separately. (See "Prevention of endocarditis: Antibiotic prophylaxis and other measures".)

The risk of prosthetic joint infection as a consequence of bacteremia following dental procedures has been controversial. This is also discussed in detail separately. (See "Prevention of prosthetic joint and other types of orthopedic hardware infection", section on 'Dental procedures'.)

Association with cardiovascular disease — An association between poor oral health and chronic periodontitis with coronary and cerebrovascular disease has been well established epidemiologically [15]. The relevant data and possible mechanisms are discussed separately. (See "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections", section on 'Association with cardiovascular risk'.)

DIAGNOSIS — Obtaining appropriate material for culture and processing it properly are important in the diagnosis of odontogenic infections. In addition, imaging techniques to assess the extent of involvement are essential.

Specimen collection and processing — One of the difficulties in defining etiologic agents for odontogenic infections is the presence of normal resident oral flora. For closed space infections, it is imperative that the normal oral flora be excluded during specimen collection in order to interpret culture results. Needle aspiration of loculated pus by an extraoral approach is desirable, and specimens should be transported immediately to the laboratory under anaerobic conditions.

However, contamination by the resident oral flora is inevitable for intraoral lesions. In this setting, direct microscopic examination of stained smears (eg, Gram stain for bacteria, calcofluor white stain for fungi) often provides more useful information than culture results from surface swabs. Tissue biopsies should be routinely examined for histopathologic evidence of acute or chronic inflammation and infection. Specific microbial agents, including certain bacterial, mycobacterial, fungal and viral infections, can sometimes be detected by immunofluorescence or polymerase chain reaction.

Patients with chronic osteomyelitis often have soft tissue swelling and draining fistulae. Bone biopsies for histopathology and culture are often required for definitive diagnosis. Aspiration of soft tissue swelling for Gram stain and culture is not helpful. Cultures from sinus tracts can be obtained but might be misleading. Since there is communication between the sinus tract and external environment, isolated microorganisms could represent colonization of the sinus tract rather than the organism responsible for the infected bone. (See "Nonvertebral osteomyelitis in adults: Clinical manifestations and diagnosis".)

Imaging techniques — The choice of imaging technique varies with the clinical setting [16]:

A panoramic or periapical radiograph may reveal the extent of advanced periodontitis or the presence of periapical abscess.

Computed tomography (CT) is particularly sensitive for osseous structures and remains the imaging modality of choice for assessment of most odontogenic infections [16]. Cone-beam CT is a fairly novel technique that reduces the amount of radiation and has become an important tool in the diagnosis of head and neck pathology, including odontogenic infection [17,18]. Dental amalgam used in fillings may cause metallic streaking artifact on CT and obscure the region of interest. This problem can be minimized with multidetector CT imaging.

For patients suspected of having deep fascial space infections of the head and neck, CT and magnetic resonance imaging (MRI) have become the preferred imaging modalities. In retropharyngeal infections, these can help determine if the infection is in the retropharyngeal space or the prevertebral space. The former suggests an odontogenic source, while the latter suggests involvement of the cervical spine. A lateral radiograph of the neck may demonstrate compression or deviation of the tracheal air column, or the presence of gas within necrotic soft tissues. (See "Deep neck space infections in adults", section on 'Clinical suspicion and urgent imaging'.)

For patients with suspected osteomyelitis, the general approach to imaging is discussed in detail elsewhere. (See "Approach to imaging modalities in the setting of suspected nonvertebral osteomyelitis", section on 'Selecting an imaging modality'.)

We do not typically use bone scan for patients with suspected bony complications of odontogenic infections. One study reported that bone scan had a 7 percent specificity and 62 percent positive predictive value for the diagnosis of mandibular osteomyelitis [19]. In addition, any dental work or trauma can make interpretation of bone scan impossible, as bony turnover can still cause false-positive technetium uptake for more than two years. Technetium bone scanning may be helpful for the diagnosis of early acute osteomyelitis if metallic scatter from dental fillings makes CT difficult to interpret. However, in chronic osteomyelitis, the technetium scans may or may not be positive, and gallium- or indium-labeled scans are often negative.

THERAPEUTIC CONSIDERATIONS — Meticulous attention to oral hygiene is the most important strategy for effective control of supragingival and subgingival plaque that, in turn, is essential for both caries prevention and the treatment of periodontitis. Individuals with physical or mental limitations who cannot adequately perform oral hygiene by themselves should receive daily oral hygiene by care providers. More frequent visits to dentists and use of electric toothbrushes should also be considered in these patients. Regular check-ups and prompt restorative care by dental professionals should be actively promoted.

With the recognition of the microbial specificity of odontogenic infections, topical antiseptics and systemic antibiotics have played an increasingly important role in the control and treatment of both dental caries and periodontal disease (table 2).

The need for dental extractions has been reduced considerably by the availability of improved dental restorative materials, such as bonding and fluoride-releasing agents, as well as improved restorative care [20].

Dental caries — Caries management with restorative therapy (eg, fillings) is the preferred therapeutic approach in many countries [20]. However, restorative therapy must be combined with preventive measures, since restorations have relatively short durability and new caries may form at the margins of restorations if the causes of the disease persist [1,20]. Caries prevention is discussed below. (See 'Prevention' below.)

Pulpitis — Pulpitis, inflammation of the dental pulp, occurs when progression of dental caries exposes the dental pulp, leading to infection (figure 3). The early and dominant symptom of acute pulpitis is a severe toothache that can be elicited by thermal changes, especially cold drinks. (See "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections", section on 'Pulpitis and periapical abscess'.)

Pulpitis can be classified as reversible or irreversible. Reversible pulpitis occurs when caries encroach on the pulp and is associated with mild inflammation of the pulp. Irreversible pulpitis refers to ongoing inflammation within the pulp chamber with rapid buildup of pressure, occlusion of blood vessels at the apical foramen, ischemia, and necrosis of the pulp tissue.

Irreversible pulpitis is characterized by acute and intense pain and is one of the most frequent reasons that patients seek emergency dental care. Apart from removal of the tooth, the customary approach to relieving the pain of irreversible pulpitis is by drilling into the tooth, removing the inflamed pulp (nerve), and cleaning the root canal. A minority of dentists begins with a trial of antibiotics and analgesics, although there is no proof of benefit from this approach.

A 2013 literature review found only one randomized controlled trial that compared treatment with systemic antibiotics to placebo in irreversible pulpitis [21]. In this trial, 40 patients were treated with analgesics and randomly assigned to either penicillin or placebo [22]. No operative endodontic treatment was performed. Although the study was limited by small sample size, no significant difference in pain intensity or use of analgesics was noted between the two groups. Photoactivated disinfection has been evaluated as an aid to mechanical irrigation in eradicating bacterial counts within the root canal during endodontic treatment [23]. It was highly effective in eliminating endodontic pathogens from the root canal [24,25]. It remains to be determined whether this approach provides incremental benefit compared to conventional endodontic treatment in symptom relief or disease progression.

Necrotizing periodontal disease — Acute necrotizing ulcerative gingivitis, also known as Vincent angina or trench mouth, should be treated with systemic antimicrobials, such as metronidazole, amoxicillin-clavulanate, or clindamycin (table 2) [26,27]. Acute necrotizing ulcerative gingivitis and periodontitis are discussed in detail elsewhere. (See "Overview of gingivitis and periodontitis in adults", section on 'Necrotizing periodontal disease'.)

Plaque-associated acute gingivitis — Acute simple gingivitis rarely requires systemic antimicrobial therapy [27,28]. Chlorhexidine 0.12% oral rinse can be used until symptoms resolve.

Systemic antibiotics are usually indicated for patients with rapidly advancing disease, severe pain, or immunocompromising condition. Possible regimens include penicillin plus metronidazole, amoxicillin-clavulanate, or clindamycin (table 2).

Rarely, patients with intense gingivostomatitis may warrant intravenous antibiotics if they cannot tolerate oral intake.

We continue antibiotics until oral lesions have healed and pain has subsided, generally for five to seven days.

Mechanical debridement (scaling and root planing of subgingival biofilm and calculus) by a dental professional and augmented oral hygiene are also warranted. (See "Overview of gingivitis and periodontitis in adults", section on 'Treatment of plaque-associated gingivitis and periodontitis' and "Overview of gingivitis and periodontitis in adults", section on 'Necrotizing periodontal disease'.)

Plaque-associated periodontitis — Due to microbial specificity in various forms of periodontitis, certain types of severe periodontitis are amenable to topical or systemic antimicrobials in conjunction with mechanical debridement (scaling and root planing) (table 2) [29]. This approach has often obviated the need for radical surgical resection of periodontal tissues.

Periodontitis in children or severe periodontitis in adults − For juvenile periodontitis [30-32] and severe adult periodontitis (Stage III or Stage IV, as indicated by the 2017 World Workshop Classification of Periodontal and Peri-implant Diseases and Conditions, based on severity and complexity of management [33]), we use amoxicillin plus metronidazole or amoxicillin-clavulanate. For patients who are penicillin allergic but who can take cephalosporins, we use an oral cephalosporin plus metronidazole. For patients who cannot take cephalosporins, other alternatives include clindamycin, azithromycin, clarithromycin, and doxycycline [34]. Clindamycin has good activity against gram-positive anaerobes but poor activity against most gram-negative anaerobes; the other antibiotics generally have poor activity against anaerobes (see "Anaerobic bacterial infections", section on 'Dental infections'). Doxycycline should be used with caution in children under eight years of age due to a small risk of tooth staining, especially with prolonged (≥21 days) courses [34] (see "Tetracyclines", section on 'Young children'). A 2015 panel of experts convened by the American Dental Association Council on Scientific Affairs recommended consideration of a three to nine-month course of oral low-dose (20 mg twice daily) doxycycline as an adjunct for scaling and root planning moderate to severe chronic periodontitis, although the evidence supporting this practice is sparse [35]. In a randomized clinical trial of patients with severe chronic periodontitis, the combination of metronidazole (250 mg or 400 mg orally three times daily) plus amoxicillin (500 mg orally three times daily) for 14 days was superior to scaling and root planing alone after one year of follow-up [36]. An earlier trial of 94 patients with advanced periodontitis had demonstrated that metronidazole or doxycycline for one to two weeks in conjunction with rigorous mechanical debridement of the root surfaces reduced the need for radical surgery by 81 percent compared with placebo [37]. However, metronidazole alone does not provide coverage against some relevant organisms (eg, Aggregatibacter actinomycetemcomitans), and tetracycline resistance among periodontal pathogens has been increasingly recognized [38].

Nonsevere periodontitis in adults − For nonsevere adult periodontitis (Stage I or Stage II, as indicated by the 2017 World Workshop Classification of Periodontal and Peri-implant Diseases and Conditions, based on severity and complexity of management [33]), topical antibiotic formulations that release controlled amounts of the antibiotic beneath the gum are used in conjunction with scaling and root planing to reduce pocket depth. Such adjunctive local antibiotics have been shown to reduce pocket depth or degree of periodontal detachment [28]. Effective agents include 2% minocycline hydrochloride microspheres (Arestin), 10% doxycycline hyclate extended-release liquid (Atridox), chlorhexidine periodontal chips, and 25% metronidazole gel (Elyzol); 25% metronidazole gel is not available in the United States and Canada [28,39,40].

The routine use of systemic antimicrobials to prevent postoperative infections following oral and/or periodontal surgery in a healthy host remains controversial [39]. In a blinded, placebo-controlled trial of 118 patients undergoing third molar extractions, a single dose of intravenous (IV) penicillin was shown to significantly reduce the incidence of surgical site infection (8.5 versus 0 percent) [41].

Duration of antibiotic therapy for periodontitis is generally seven to 14 days. For patients with mild periodontitis whose symptoms have resolved, seven days of topical antibiotic therapy is usually sufficient. For severe periodontitis, we generally continue antibiotics for 14 days or until clinical resolution [42].

Suppurative odontogenic infections

Drainage — The most important therapeutic modality for pyogenic odontogenic infections is drainage and removal of necrotic tissue. Needle aspiration by the extraoral route can be particularly helpful both for microbiologic sampling and for evacuation of pus. In a study of 15 patients with oral-maxillofacial abscesses who underwent needle aspiration of abscess, all patients reported a reduction in pain and none required further surgical incision and drainage [43]. The need for definitive restoration or extraction of the infected tooth, the primary source of infection, is usually readily apparent. Deep periodontal scaling and endodontic treatments with root filling is required in most instances.

Effective surgical management requires a thorough understanding of the most likely anatomic routes of spread. The neighboring potential fascial spaces should be carefully and systematically surveyed. The optimum timing for incision and drainage is equally important. Premature incision into an area of cellulitis in an ill-conceived search for pus can disrupt the normal physiologic barrier and cause extension of infection.

Antibiotic therapy — Antibiotic therapy can halt the local spread of infection and prevent hematogenous dissemination.

Indications — Antimicrobial agents are generally indicated if fever and regional lymphadenopathy are present, or when infection has perforated the bony cortex and spread into surrounding soft tissue. Severely immunocompromised patients are particularly at risk for spreading orofacial infections, and empiric broad spectrum antimicrobial therapy in these patients is warranted [3,44].

Initial empiric therapy — For patients with pyogenic odontogenic infections, we favor parenteral therapy initially. However, for adult patients with mild infections and without comorbidities or signs of sepsis, it is reasonable to give an oral regimen while arranging for the patient to see a dentist or oral surgeon. Oral regimens are discussed elsewhere. (See 'Oral step-down therapy and duration of therapy' below.)

The choice of specific antibiotics for the treatment of odontogenic infections is based more upon knowledge of the indigenous organisms that colonize the teeth, gums, and mucous membranes, as well as specific cariogenic and periodontopathic pathogens associated with clinical disease, rather than upon the results of culture and susceptibility testing [27,28]. The microbiology and, thus, the empiric regimens differ between immunocompetent and severely immunocompromised (eg, patients with leukemia and severe neutropenia after chemotherapy) (table 3):

Immunocompetent patients − For most patients, ampicillin-sulbactam (3 g IV every six hours) is the treatment of choice. An alternative is penicillin G (2 to 4 million units IV every four to six hours) in combination with metronidazole (500 mg IV or orally every eight hours) (table 3). These regimens cover mouth flora streptococci and anaerobes, including those that produce beta-lactamase. Beta-lactamase production among oral anaerobes, particularly pigmented Prevotella spp and Fusobacterium spp, is increasingly recognized, and treatment failure with penicillin alone has been well documented [45]. Thus, penicillin monotherapy is no longer recommended. Although metronidazole is highly active against anaerobic gram-negative bacilli and spirochetes, it is only moderately active against anaerobic cocci and is not active against aerobes, including streptococci. As a result, it should not be used as a single agent in suppurative odontogenic infections.

In patients with a nonsevere penicillin allergy, we prefer second- or third-generation cephalosporin (eg, cefoxitin 2 g IV every six hours, cefotetan 2 g IV every 12 hours, or ceftriaxone 2 g IV every 24 hours) plus metronidazole (500 mg IV or orally every eight hours). For patients with severe penicillin allergies who cannot tolerate cephalosporins, options include metronidazole (500 mg IV or orally every eight hours) plus levofloxacin (750 mg IV or orally every 24 hours) or meropenem (1 g IV every eight hours). Clindamycin is not recommended for initial empiric therapy due to resistance among mouth flora streptococci, such as Streptococcus anginosus (milleri) group (20 to 30 percent), and among anaerobes, such as Prevotella spp and Porphyromonas spp (31 to 38 percent) [46,47]. Macrolides (eg, erythromycin, clarithromycin, azithromycin) and tetracyclines (eg, doxycycline) are not recommended because of increasing resistance among some strains of streptococci and their lack of optimal anaerobic activity [48,49].

Immunocompromised patients − For severely immunocompromised patients, it is prudent to additionally cover for facultative gram-negative bacilli (including Pseudomonas spp) with agents that have broad-spectrum activity against both aerobes and anaerobes. Appropriate regimens are listed in the table (table 3).

In addition, for patients with risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection, we typically add vancomycin (or other MRSA-active antibiotic) to the initial empiric regimen; if MRSA is not isolated on cultures, coverage for this organism can be discontinued. Risk factors for MRSA and antibiotics active against MRSA are discussed elsewhere. (See "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology", section on 'Risk factors' and "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of bacteremia", section on 'Treatment regimens'.)

Oral step-down therapy and duration of therapy — For patients with odontogenic soft tissue infections, we continue IV therapy until there is evidence of clinical improvement, which usually occurs within three to five days following initiation of antibiotics and abscess drainage in those with severe infections and within a shorter period in those with mild to moderate infections. Some patients with mild infection may also receive oral therapy initially, pending dental or surgical evaluation.

The preferred oral regimen is amoxicillin-clavulanate (875 mg orally twice daily). For penicillin-allergic patients who can tolerate cephalosporins, we usually give a second- or third-generation oral cephalosporin (eg, cefuroxime 500 mg orally twice daily, cefdinir 300 mg orally twice daily, or cefpodoxime 400 mg orally twice daily) plus metronidazole. If both penicillins and cephalosporins cannot be tolerated, we prefer levofloxacin plus metronidazole. Clindamycin 300 mg to 450 mg orally three times daily is another option but should be avoided if clindamycin resistance is suspected (eg, based on local epidemiology) or documented.

Antibiotics should be continued until local inflammation has resolved completely, typically for a total of 7 to 14 days.

Osteomyelitis — Treatment of osteomyelitis of the jaw is complicated by the presence of teeth and persistent exposure to the oral environment. Antibiotic regimens should ideally be informed by culture of a bone biopsy specimen. When culture results are uninformative or unavailable, we use antibiotics with activity against streptococci and anaerobes. Appropriate antibiotic regimens include ampicillin-sulbactam, ceftriaxone plus metronidazole, or ertapenem. For immunocompromised patients who are at increased risk for Pseudomonas aeruginosa, appropriate antibiotic regimens include piperacillin-tazobactam, cefepime plus metronidazole, or meropenem (table 3). Oral options for jaw osteomyelitis include clindamycin or levofloxacin but should only be used when susceptibility has been confirmed by culture data. Antibiotic therapy needs to be prolonged, often for weeks to months.

The benefit of adjuvant therapy with hyperbaric oxygen has not been demonstrated [50,51]. (See "Hyperbaric oxygen therapy".)

Surgical management, including sequestrectomy, saucerization, decortication, and closed-wound suction irrigation, is occasionally necessary. Rarely, in advanced cases, the entire segment of the infected jaw has to be resected [8].

PREVENTION — The single most cost-effective measure for reducing dental caries is fluoridation of public water supplies [52,53]. Fluoride forms a complex with the apatite crystals in dentin by replacing the hydroxyl group, thereby lending strength to the entire structure. Fluoride also promotes remineralization of carious lesions and exerts a bacteriostatic effect.

In addition to fluoridated water, brushing two to three times daily with a fluoridated toothpaste (1000 ppm of fluoride, usually as sodium fluoride 1.1% or stannous fluoride 0.4%) effectively delivers fluoride to the tooth-plaque surface [54]. In high-risk individuals, additional fluoride therapy in the form of fluoride varnishes (22,600 ppm fluoride as 5% sodium fluoride, professionally applied three or four times a year) has been effective in caries prevention [20].

The key for the prevention and control of dental caries and advanced periodontitis is the active promotion of oral hygiene. The components of such a regimen include:

Regular brushing with a fluoridated toothpaste and dental flossing after each meal

Dietary counseling to reduce the ingestion of sugar-rich foods or beverages

Use of topical fluorides and oral antimicrobial rinses, such as chlorhexidine for high-risk patients

Modification of risk factors, such as smoking cessation

Overcoming the reluctance for regular visits to dental professionals

It is also important to dispel the common misconception by physicians and patients that progressive dental caries, gingival disease, and loss of teeth is an inevitable and irreversible part of aging. The current lack of motivation of both patients and healthcare providers for regular and rigorous preventative dental care must be reversed.

A variety of other measures have been effective for caries prevention. None of these measures is routinely applied in clinical practice, but they are useful in selected patients with rampant caries [55].

Xylitol gum, a nonfermentable five-carbon sugar, as a sugar substitute between meals [56].

Oral antimicrobial rinses with 0.12% chlorhexidine help to control dental plaque bacteria but have no proven effect on dental caries [55,57]. On the other hand, a meta-analysis found that application of 0.12% chlorhexidine varnish during fixed orthodontic treatment was effective in reducing caries incidence [58]. Chlorhexidine has a bitter taste, stains the enamel and tongue, and prolonged application can promote the emergence of resistant microorganisms.

Among topical antibiotics, only vancomycin has been shown to reduce dental caries with some degree of success in humans [55,59].

Oral probiotics may be effective for caries prevention and treatment of periodontal disease in certain high-risk populations [60-62]. More investigations are necessary to define their role in oral health and disease.

Vaccines based upon various immunogens derived from Streptococcus mutans, the principal bacterial agent associated with dental caries, have been explored [63]. However, the prospect for an effective and safe vaccine remains remote and unlikely to be available for clinical application in the near future. The need for and appropriate frequency of routine dental scaling and polishing in patients at low risk for periodontal disease is uncertain [64].

ANTIMICROBIAL PROPHYLAXIS — Recommendations regarding the use of antimicrobial prophylaxis to prevent bacterial endocarditis and prosthetic joint infections in selected patients undergoing dental procedures are presented separately. (See "Prevention of endocarditis: Antibiotic prophylaxis and other measures" and "Prevention of prosthetic joint and other types of orthopedic hardware infection", section on 'Dental procedures'.)

SUMMARY AND RECOMMENDATIONS

Definition − Odontogenic infections consist primarily of dental caries and periodontal disease (gingivitis and periodontitis), are common and have local (eg, tooth loss) and, in some cases, systemic implications. (See 'Introduction' above.)

Complications – Odontogenic infections can have local (eg, tooth loss) and systemic implications. Suppurative odontogenic infections may extend to potential fascial spaces in the orofacial area (orofacial space infections) or deep in the head and neck (peripharyngeal space infections) and can also result in osteomyelitis of the jaw or hematogenous dissemination, which may in turn cause endocarditis or prosthetic joint infections. (See 'Complications' above.)

Specimen collection and processing − For closed space infections, it is imperative that the normal oral flora be excluded during specimen collection in order to interpret culture results. Needle aspiration of loculated pus by an extraoral approach is desirable, and specimens should be transported immediately to the laboratory under anaerobic conditions. (See 'Specimen collection and processing' above.)

Preferred imaging modality − The choice of imaging technique varies with the clinical setting. Computed tomography (CT) is particularly sensitive for osseous structures and remains the imaging modality of choice for assessment of most odontogenic infections. (See 'Imaging techniques' above.)

Management

Oral hygiene − Meticulous attention to oral hygiene is essential for both caries prevention and the treatment of periodontitis. (See 'Therapeutic considerations' above.)

Pulpitis − The customary approach to relieving the pain of irreversible pulpitis is by drilling into the tooth, removing the inflamed pulp (nerve), and cleaning the root canal. Sometimes tooth removal is necessary. (See 'Pulpitis' above.)

Acute simple gingivitis − Acute simple gingivitis rarely requires systemic antimicrobial therapy. Chlorhexidine 0.12% oral rinse can be used in most cases. Antibiotics are usually indicated for patients with rapidly advancing disease, severe pain, or an immunocompromising condition. Possible regimens include penicillin plus metronidazole, amoxicillin-clavulanate, or clindamycin (table 2). (See 'Plaque-associated acute gingivitis' above.)

Acute necrotizing ulcerative gingivitis − Acute necrotizing ulcerative gingivitis, also known as Vincent angina or trench mouth, should be treated with systemic antimicrobials, such as metronidazole, amoxicillin-clavulanate, or clindamycin (table 2). (See 'Plaque-associated acute gingivitis' above.)

Periodontitis − Certain types of severe periodontitis (Stage III or IV) are amenable to systemic antimicrobials in conjunction with mechanical debridement (scaling and root planing) (table 2). This approach has often obviated the need for radical surgical resection of periodontal tissues. For less severe periodontitis (Stage I or II), a topical antibiotic approach is used in conjunction with scaling and root planing. (See 'Plaque-associated periodontitis' above.)

Suppurative odontogenic infections

-Surgical drainage and removal of necrotic tissue is the most important therapeutic modality for pyogenic odontogenic infections. Needle aspiration by the extraoral route can be particularly helpful both for microbiologic sampling and for evacuation of pus. The need for definitive restoration or extraction of the infected tooth, the primary source of infection, is usually readily apparent. Deep periodontal scaling and endodontic treatments with root filling is required in most instances. (See 'Suppurative odontogenic infections' above.)

-Antimicrobial therapy is generally indicated in addition to surgical management if fever and regional lymphadenopathy are present, or when infection has perforated the bony cortex and spread into surrounding soft tissue. Ampicillin-sulbactam (3 g intravenously every six hours) provides extended coverage against oral anaerobes, including those that produce beta-lactamases, and is the treatment of choice in immunocompetent patients (table 3). (See 'Antibiotic therapy' above.)

Prevention − The single most cost-effective measure for reducing dental caries is fluoridation of public water supplies. Other preventive measures include regular brushing with a fluoridated toothpaste, dental flossing, and reducing the ingestion of sugar-rich foods or beverages. (See 'Prevention' above.)

  1. Beltrán-Aguilar ED, Barker LK, Canto MT, et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveill Summ 2005; 54:1.
  2. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999; 70:13.
  3. Chow A.. Infections of the oral cavity, neck and head. In: Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 9th ed, Bennett JE, Dolin R, Blaser MJ (Eds), Elsevier, Philadephia 2020. p.859.
  4. Mesgarzadeh AH, Ghavimi MA, Gok G, Zarghami A. Infratemporal space infection following maxillary third molar extraction in an uncontrolled diabetic patient. J Dent Res Dent Clin Dent Prospects 2012; 6:113.
  5. Prasad KC, Prasad SC, Mouli N, Agarwal S. Osteomyelitis in the head and neck. Acta Otolaryngol 2007; 127:194.
  6. Tong AC, Ng IO, Yeung KM. Osteomyelitis with proliferative periostitis: an unusual case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:e14.
  7. Kannan SK, Sandhya G, Selvarani R. Periostitis ossificans (Garrè's osteomyelitis) radiographic study of two cases. Int J Paediatr Dent 2006; 16:59.
  8. Sharkawy AA. Cervicofacial actinomycosis and mandibular osteomyelitis. Infect Dis Clin North Am 2007; 21:543.
  9. Hong SO, Lee CY, Jung J, et al. A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians. Clin Oral Investig 2016.
  10. Bartzokas CA, Johnson R, Jane M, et al. Relation between mouth and haematogenous infection in total joint replacements. BMJ 1994; 309:506.
  11. Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010; 50:8.
  12. Takai S, Kuriyama T, Yanagisawa M, et al. Incidence and bacteriology of bacteremia associated with various oral and maxillofacial surgical procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99:292.
  13. Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008; 168:2095.
  14. Terezhalmy GT, Safadi TJ, Longworth DL, Muehrcke DD. Oral disease burden in patients undergoing prosthetic heart valve implantation. Ann Thorac Surg 1997; 63:402.
  15. Suzuki J, Aoyama N, Ogawa M, et al. Periodontitis and cardiovascular diseases. Expert Opin Ther Targets 2010; 14:1023.
  16. Hurley MC, Heran MK. Imaging studies for head and neck infections. Infect Dis Clin North Am 2007; 21:305.
  17. Dumitrescu A, Martu MA, Nemtoi A, et al. Association between Cone-Beam Computed Tomography and Histological and Immunohistochemical Features in Periapical Lesions Correlated with Thickened Maxillary Sinus Mucosa. Medicina (Kaunas) 2021; 57.
  18. Tofangchiha M, Ramezani K. Cone beam computed tomography, an overlooked modality in validated image ordering guidelines for odontogenic infections. Int J Oral Maxillofac Surg 2022; 51:577.
  19. Boronat-Ferrater M, Simó-Perdigó M, Cuberas-Borrós G, et al. Bone scintigraphy and radiolabeled white blood cell scintigraphy for the diagnosis of mandibular osteomyelitis. Clin Nucl Med 2011; 36:273.
  20. Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet 2007; 369:51.
  21. Fedorowicz Z, van Zuuren EJ, Farman AG, et al. Antibiotic use for irreversible pulpitis. Cochrane Database Syst Rev 2013; :CD004969.
  22. Nagle D, Reader A, Beck M, Weaver J. Effect of systemic penicillin on pain in untreated irreversible pulpitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90:636.
  23. Schlafer S, Vaeth M, Hørsted-Bindslev P, Frandsen EV. Endodontic photoactivated disinfection using a conventional light source: an in vitro and ex vivo study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109:634.
  24. Williams JA, Pearson GJ, Colles MJ. Antibacterial action of photoactivated disinfection {PAD} used on endodontic bacteria in planktonic suspension and in artificial and human root canals. J Dent 2006; 34:363.
  25. Bonsor SJ, Nichol R, Reid TM, Pearson GJ. Microbiological evaluation of photo-activated disinfection in endodontics (an in vivo study). Br Dent J 2006; 200:337.
  26. Baker KA, Fotos PG. The management of odontogenic infections. A rationale for appropriate chemotherapy. Dent Clin North Am 1994; 38:689.
  27. Hull MW, Chow AW. An Approach to Oral Infections and Their Management. Curr Infect Dis Rep 2005; 7:17.
  28. Krayer JW, Leite RS, Kirkwood KL. Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases. Dent Clin North Am 2010; 54:13.
  29. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002; 28:106.
  30. Al-Ghutaimel H, Riba H, Al-Kahtani S, Al-Duhaimi S. Common periodontal diseases of children and adolescents. Int J Dent 2014; 2014:850674.
  31. Califano JV, Research, Science and Therapy Committee American Academy of Periodontology. Position paper: periodontal diseases of children and adolescents. J Periodontol 2003; 74:1696.
  32. Research Science and Therapy Committee Guidelines. Periodontal diseases of children and adolescents. J Periodontol 2003; 74:1696.
  33. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol 2018; 89 Suppl 1:S159.
  34. Hammami C, Nasri W. Antibiotics in the Treatment of Periodontitis: A Systematic Review of the Literature. Int J Dent 2021; 2021:6846074.
  35. Smiley CJ, Tracy SL, Abt E, et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc 2015; 146:508.
  36. Borges I, Faveri M, Figueiredo LC, et al. Different antibiotic protocols in the treatment of severe chronic periodontitis: a 1-year randomized trial. J Clin Periodontol 2017.
  37. Loesche WJ, Giordano J, Soehren S, et al. Nonsurgical treatment of patients with periodontal disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81:533.
  38. Warburton PJ, Palmer RM, Munson MA, Wade WG. Demonstration of in vivo transfer of doxycycline resistance mediated by a novel transposon. J Antimicrob Chemother 2007; 60:973.
  39. Little JW, Falace DA, Miller CS, Rhodus NL. Antibiotic prophylaxis in dentistry: an update. Gen Dent 2008; 56:20.
  40. Panhwar M, Rajpar SP, Abrar E, et al. Effectiveness of Chlorhexidine and Metronidazole Gels in the management of gingivitis. A clinical trial. Pak J Med Sci 2021; 37:1425.
  41. Halpern LR, Dodson TB. Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory complications after third molar surgery? J Oral Maxillofac Surg 2007; 65:177.
  42. McGowan K, McGowan T, Ivanovski S. Optimal dose and duration of amoxicillin-plus-metronidazole as an adjunct to non-surgical periodontal therapy: A systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Periodontol 2018; 45:56.
  43. Shi H, Yang Z, Li H, et al. Efficacy of needle aspiration in patients with oral-maxillofacial abscesses: A retrospective study of 15 consecutive patients. Am J Otolaryngol 2022; 43:103216.
  44. Caruso SR, Yamaguchi E, Portnof JE. Update on Antimicrobial Therapy in Management of Acute Odontogenic Infection in Oral and Maxillofacial Surgery. Oral Maxillofac Surg Clin North Am 2022; 34:169.
  45. Brook I. Antibiotic resistance of oral anaerobic bacteria and their effect on the management of upper respiratory tract and head and neck infections. Semin Respir Infect 2002; 17:195.
  46. Marchand-Austin A, Rawte P, Toye B, et al. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011. Anaerobe 2014; 28:120.
  47. Wybo I, Van den Bossche D, Soetens O, et al. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 2014; 69:155.
  48. Poeschl PW, Spusta L, Russmueller G, et al. Antibiotic susceptibility and resistance of the odontogenic microbiological spectrum and its clinical impact on severe deep space head and neck infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110:151.
  49. Rossi-Fedele G, Scott W, Spratt D, et al. Incidence and behaviour of Tn916-like elements within tetracycline-resistant bacteria isolated from root canals. Oral Microbiol Immunol 2006; 21:218.
  50. Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws--a current overview--Part 2: dental management and therapeutic options for treatment. Oral Maxillofac Surg 2010; 14:81.
  51. Lentrodt S, Lentrodt J, Kübler N, Mödder U. Hyperbaric oxygen for adjuvant therapy for chronically recurrent mandibular osteomyelitis in childhood and adolescence. J Oral Maxillofac Surg 2007; 65:186.
  52. Ran T, Chattopadhyay SK, Community Preventive Services Task Force. Economic Evaluation of Community Water Fluoridation: A Community Guide Systematic Review. Am J Prev Med 2016; 50:790.
  53. O'Connell J, Rockell J, Ouellet J, et al. Costs And Savings Associated With Community Water Fluoridation In The United States. Health Aff (Millwood) 2016; 35:2224.
  54. Hicks J, Garcia-Godoy F, Flaitz C. Biological factors in dental caries: role of remineralization and fluoride in the dynamic process of demineralization and remineralization (part 3). J Clin Pediatr Dent 2004; 28:203.
  55. Caufield PW, Dasanayake AP, Li Y. The antimicrobial approach to caries management. J Dent Educ 2001; 65:1091.
  56. Janakiram C, Deepan Kumar CV, Joseph J. Xylitol in preventing dental caries: A systematic review and meta-analyses. J Nat Sci Biol Med 2017; 8:16.
  57. Forgie AH, Paterson M, Pine CM, et al. A randomised controlled trial of the caries-preventive efficacy of a chlorhexidine-containing varnish in high-caries-risk adolescents. Caries Res 2000; 34:432.
  58. Okada EM, Ribeiro LN, Stuani MB, et al. Effects of chlorhexidine varnish on caries during orthodontic treatment: a systematic review and meta-analysis. Braz Oral Res 2016; 30:e115.
  59. DePaola PF, Jordan HV, Soparkar PM. Inhibition of dental caries in school children by topically applied vancomycin. Arch Oral Biol 1977; 22:187.
  60. Rodríguez G, Ruiz B, Faleiros S, et al. Probiotic Compared with Standard Milk for High-caries Children: A Cluster Randomized Trial. J Dent Res 2016; 95:402.
  61. Kobayashi R, Kobayashi T, Sakai F, et al. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. Sci Rep 2017; 7:545.
  62. Alok A, Singh ID, Singh S, et al. Probiotics: A New Era of Biotherapy. Adv Biomed Res 2017; 6:31.
  63. Smith DJ. Dental caries vaccines: prospects and concerns. Expert Rev Vaccines 2010; 9:1.
  64. Beirne P, Forgie A, Worthington HV, Clarkson JE. Routine scale and polish for periodontal health in adults. Cochrane Database Syst Rev 2005; :CD004625.
Topic 3416 Version 32.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟